Adopt New Preclinical Strategies for Guaranteed Clinical Success
The Annual Tumour Models London Summit is back to share the best preclinical research that demonstrates predictability and effectively recapitulates human biology.
Scientists are continuing to scrutinise preclinical oncology models to find data that mimics the complexities of human cancer. The money and time wasted on immuno-oncology programs means there’s a growing pressure to evaluate new preclinical developments that bridge the gap between preclinical knowledge and clinical utility.
Join pharma, biotech and academic institutions who will reveal unpublished discoveries and preclinical case studies that use in vivo, ex vivo and in vitro models. Learn from the successes and failures of humanized mouse models to accurately predict human responses and future proof clinical success.
So cap off the year by joining the most trusted forum dedicated to preclinical oncology. Equip your future research with exclusive data to maximise the potential of your discoveries.
“Outstanding meeting with first class speakers. I learned a lot and I will certainly recommend the meeting to my colleagues” – Past Tumour Models London attendee, Sanofi Aventis